There has been an excellent article published in The Times today about the groundbreaking 5,000 patient trial by one of our subsidiary companies LVL Health Medical Cannabis Clinic to study the use of medicinal cannabis to treat chronic pain.
Celadon Pharmaceuticals Plc is getting ready to become the provider of medical-grade cannabis for the trial grown here in the UK. Celadon has recently become the first medical cannabinoid company to float on the AIM London Stock Exchange since GW Pharma.
Recent Comments